SuRo Cost Of Revenue vs Ebit Per Revenue Analysis

SSSS Stock

USD 6.14 0.14 2.23%

SuRo Capital financial indicator trend analysis is much more than just breaking down SuRo Capital Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether SuRo Capital Corp is a good investment. Please check the relationship between SuRo Capital Cost Of Revenue and its Ebit Per Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SuRo Capital Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Cost Of Revenue vs Ebit Per Revenue

Cost Of Revenue vs Ebit Per Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of SuRo Capital Corp Cost Of Revenue account and Ebit Per Revenue. At this time, the significance of the direction appears to have almost no relationship.

The correlation between SuRo Capital's Cost Of Revenue and Ebit Per Revenue is 0.17. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of SuRo Capital Corp, assuming nothing else is changed. The correlation between historical values of SuRo Capital's Cost Of Revenue and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of SuRo Capital Corp are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Cost Of Revenue i.e., SuRo Capital's Cost Of Revenue and Ebit Per Revenue go up and down completely randomly.

Correlation Coefficient

0.17

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on SuRo Capital Corp income statement and represents the costs associated with goods and services SuRo Capital provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Ebit Per Revenue

Most indicators from SuRo Capital's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into SuRo Capital Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SuRo Capital Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Selling General Administrative is likely to drop to about 9.5 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year

SuRo Capital fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Retained Earnings	Short Long Term Debt Total	Other Assets	Short Term Debt	Current Deferred Revenue
Total Assets		-0.05	0.48	0.91	0.01	0.58	0.44	0.93	0.19	-0.07	0.36	0.59	0.68	0.4	0.13	0.17	0.34	0.62	0.83	-0.07	0.69	0.51	0.09	-0.17	0.18	0.15
Other Current Liab	-0.05		0.04	-0.05	-0.25	-0.11	0.19	-0.22	0.29	0.47	0.13	-0.38	-0.47	0.34	0.05	0.43	-0.29	-0.35	-0.03	0.47	-0.29	0.17	0.19	-0.14	0.04	0.21
Total Current Liabilities	0.48	0.04		0.15	0.0	0.93	0.06	0.47	0.24	-0.09	-0.07	-0.06	0.07	0.48	0.62	0.01	0.38	-0.12	0.77	-0.08	-0.03	0.52	0.41	-0.61	0.62	0.34
Total Stockholder Equity	0.91	-0.05	0.15		-0.17	0.29	0.55	0.8	-0.07	0.04	0.5	0.65	0.68	0.16	-0.07	0.15	0.21	0.73	0.51	0.04	0.76	0.41	-0.1	0.03	-0.09	-0.02
Net Debt	0.01	-0.25	0.0	-0.17		-0.04	-0.8	0.34	0.18	-0.87	-0.74	0.0	0.01	0.46	-0.04	0.21	-0.15	0.1	0.25	-0.87	-0.11	-0.15	0.16	0.0	0.11	0.25
Accounts Payable	0.58	-0.11	0.93	0.29	-0.04		0.1	0.56	0.21	-0.11	0.07	0.03	0.18	0.34	0.33	-0.06	0.52	-0.01	0.8	-0.1	0.07	0.58	0.21	-0.31	0.51	0.13
Cash	0.44	0.19	0.06	0.55	-0.8	0.1		0.09	0.12	0.79	0.88	0.46	0.47	-0.2	0.14	-0.12	0.25	0.31	0.16	0.8	0.59	0.16	-0.02	-0.11	-0.05	-0.1
Non Current Assets Total	0.93	-0.22	0.47	0.8	0.34	0.56	0.09		0.1	-0.44	0.03	0.55	0.65	0.49	0.09	0.22	0.32	0.63	0.82	-0.44	0.6	0.45	0.13	-0.14	0.23	0.22
Non Currrent Assets Other	0.19	0.29	0.24	-0.07	0.18	0.21	0.12	0.1		0.18	0.17	0.03	0.14	0.17	0.06	0.08	0.15	-0.15	0.48	0.18	0.03	0.14	0.1	-0.08	0.14	0.12
Cash And Short Term Investments	-0.07	0.47	-0.09	0.04	-0.87	-0.11	0.79	-0.44	0.18		0.77	-0.07	-0.1	-0.35	0.06	-0.19	-0.05	-0.2	-0.2	1.0	0.04	0.03	-0.12	-0.02	-0.19	-0.22
Net Receivables	0.36	0.13	-0.07	0.5	-0.74	0.07	0.88	0.03	0.17	0.77		0.42	0.39	-0.35	-0.17	-0.14	0.1	0.3	0.08	0.78	0.52	0.1	-0.24	0.2	-0.26	-0.29
Common Stock Total Equity	0.59	-0.38	-0.06	0.65	0.0	0.03	0.46	0.55	0.03	-0.07	0.42		0.93	0.07	0.04	0.08	0.24	0.75	0.33	-0.06	0.96	-0.08	0.13	-0.06	0.04	0.11
Common Stock Shares Outstanding	0.68	-0.47	0.07	0.68	0.01	0.18	0.47	0.65	0.14	-0.1	0.39	0.93		0.05	0.08	-0.02	0.42	0.81	0.47	-0.09	0.94	-0.04	0.07	-0.07	0.08	0.08
Short Term Investments	0.4	0.34	0.48	0.16	0.46	0.34	-0.2	0.49	0.17	-0.35	-0.35	0.07	0.05		0.36	0.46	-0.12	0.1	0.59	-0.35	0.09	0.14	0.49	-0.45	0.38	0.7
Non Current Liabilities Total	0.13	0.05	0.62	-0.07	-0.04	0.33	0.14	0.09	0.06	0.06	-0.17	0.04	0.08	0.36		-0.07	0.0	-0.08	0.33	0.06	0.05	0.04	0.6	-0.98	0.53	0.53
Inventory	0.17	0.43	0.01	0.15	0.21	-0.06	-0.12	0.22	0.08	-0.19	-0.14	0.08	-0.02	0.46	-0.07		-0.1	0.04	0.14	-0.19	0.09	0.22	0.15	-0.15	0.11	0.53
Other Current Assets	0.34	-0.29	0.38	0.21	-0.15	0.52	0.25	0.32	0.15	-0.05	0.1	0.24	0.42	-0.12	0.0	-0.1		0.14	0.42	-0.03	0.27	0.25	0.19	0.02	0.52	-0.21
Other Stockholder Equity	0.62	-0.35	-0.12	0.73	0.1	-0.01	0.31	0.63	-0.15	-0.2	0.3	0.75	0.81	0.1	-0.08	0.04	0.14		0.28	-0.19	0.83	-0.26	-0.03	0.07	-0.12	-0.04
Total Liab	0.83	-0.03	0.77	0.51	0.25	0.8	0.16	0.82	0.48	-0.2	0.08	0.33	0.47	0.59	0.33	0.14	0.42	0.28		-0.2	0.39	0.49	0.32	-0.36	0.46	0.32
Total Current Assets	-0.07	0.47	-0.08	0.04	-0.87	-0.1	0.8	-0.44	0.18	1.0	0.78	-0.06	-0.09	-0.35	0.06	-0.19	-0.03	-0.19	-0.2		0.05	0.04	-0.12	-0.02	-0.18	-0.22
Common Stock	0.69	-0.29	-0.03	0.76	-0.11	0.07	0.59	0.6	0.03	0.04	0.52	0.96	0.94	0.09	0.05	0.09	0.27	0.83	0.39	0.05		-0.07	0.14	-0.07	0.06	0.13
Retained Earnings	0.51	0.17	0.52	0.41	-0.15	0.58	0.16	0.45	0.14	0.03	0.1	-0.08	-0.04	0.14	0.04	0.22	0.25	-0.26	0.49	0.04	-0.07		-0.16	-0.09	0.09	0.06
Short Long Term Debt Total	0.09	0.19	0.41	-0.1	0.16	0.21	-0.02	0.13	0.1	-0.12	-0.24	0.13	0.07	0.49	0.6	0.15	0.19	-0.03	0.32	-0.12	0.14	-0.16		-0.63	0.89	0.57
Other Assets	-0.17	-0.14	-0.61	0.03	0.0	-0.31	-0.11	-0.14	-0.08	-0.02	0.2	-0.06	-0.07	-0.45	-0.98	-0.15	0.02	0.07	-0.36	-0.02	-0.07	-0.09	-0.63		-0.55	-0.65
Short Term Debt	0.18	0.04	0.62	-0.09	0.11	0.51	-0.05	0.23	0.14	-0.19	-0.26	0.04	0.08	0.38	0.53	0.11	0.52	-0.12	0.46	-0.18	0.06	0.09	0.89	-0.55		0.46
Current Deferred Revenue	0.15	0.21	0.34	-0.02	0.25	0.13	-0.1	0.22	0.12	-0.22	-0.29	0.11	0.08	0.7	0.53	0.53	-0.21	-0.04	0.32	-0.22	0.13	0.06	0.57	-0.65	0.46

Click cells to compare fundamentals

SuRo Capital Account Relationship Matchups

SuRo Capital fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	288.6M	478.9M	462.3M	284.4M	277.6M	373.0M
Other Current Liab	4.0M	(633.7K)	24.0M	(288.3K)	266.1K	252.8K
Total Current Liabilities	49.8M	139.3M	24.4M	716.7K	498.8K	473.9K
Total Stockholder Equity	199.9M	301.6M	364.8M	210.0M	203.4M	257.1M
Net Debt	(6.1M)	(7.8M)	(125.4M)	33.6M	45.6M	47.8M
Accounts Payable	45.9M	139.9M	24.4M	1.0M	498.8K	473.9K
Cash	44.9M	45.8M	198.4M	40.1M	28.2M	41.4M
Non Current Assets Total	241.6M	431.7M	261.2M	243.1M	248.6M	322.6M
Non Currrent Assets Other	(775.7K)	297.2K	621.7K	555.8K	594.7K	624.5K
Cash And Short Term Investments	44.9M	45.8M	198.4M	40.1M	28.2M	49.1M
Net Receivables	84.6K	1.0M	2.2M	767.1K	441.9K	441.6K
Common Stock Total Equity	197.6K	175.6K	199.1K	284.3K	326.9K	214.8K
Common Stock Shares Outstanding	23.1M	21.8M	26.8M	30.0M	26.2M	23.0M
Short Term Investments	320.6T	1.0	231.8M	130.9M	117.8M	111.9M
Liabilities And Stockholders Equity	288.6M	478.9M	462.3M	284.4M	277.6M	372.4M
Non Current Liabilities Total	38.8M	38.0M	73.0M	73.7M	73.7M	70.1M
Other Current Assets	2.0M	985.6K	938.0K	727.0K	691.4K	948.0K
Other Stockholder Equity	204.2M	221.8M	285.5M	387.2M	207.4M	259.0M
Total Liab	88.6M	177.3M	97.5M	74.4M	74.2M	115.3M
Total Current Assets	47.0M	47.2M	201.1M	41.3M	29.3M	50.4M
Common Stock	175.6K	199.1K	311.2K	284.3K	254.5K	229.6K
Retained Earnings	21.2M	79.6M	14.5M	(121.2M)	(4.3M)	(4.1M)
Short Long Term Debt Total	39.0M	38.0M	73.0M	73.7M	73.7M	65.6M
Other Assets	1.8M	1.3M	1.6M	(129.0M)	(309.3K)	(324.8K)
Net Tangible Assets	199.9M	301.6M	364.8M	358.8M	412.6M	286.7M
Capital Surpluse	202.6M	192.3M	178.6M	330.9M	380.5M	249.9M
Deferred Long Term Liab	11.4K	297.2K	621.7K	555.8K	639.1K	389.2K
Long Term Investments	241.6M	430.8M	260.1M	242.2M	247.9M	241.2M
Net Invested Capital	238.7M	339.0M	437.9M	283.4M	277.1M	327.3M
Capital Stock	175.6K	199.1K	311.2K	284.3K	254.5K	260.8K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for SuRo Stock Analysis

When running SuRo Capital's price analysis, check to measure SuRo Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SuRo Capital is operating at the current time. Most of SuRo Capital's value examination focuses on studying past and present price action to predict the probability of SuRo Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SuRo Capital's price. Additionally, you may evaluate how the addition of SuRo Capital to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC